Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 20;19(9):4978.
doi: 10.3390/ijerph19094978.

Pharmacological Treatment of Acute Psychiatric Symptoms in COVID-19 Patients: A Systematic Review and a Case Series

Claudia Carmassi  1 , Bruno Pacciardi  1 , Davide Gravina  1 , Sara Fantasia  1 , Gennaro De Pascale  2 , Salvatore Lucio Cutuli  2 , Carlo Antonio Bertelloni  1 , Liliana Dell'Osso  1
Affiliations

Pharmacological Treatment of Acute Psychiatric Symptoms in COVID-19 Patients: A Systematic Review and a Case Series

Claudia Carmassi et al. Int J Environ Res Public Health. .

Abstract

Delirium and psychomotor agitation are relevant clinical conditions that may develop during COVID-19 infection, especially in intensive care unit (ICU) settings. The psychopharmacological management of these conditions is receiving increasing interest in psychiatry, considering hyperkinetic delirium as one of the most common neuropsychiatries acute consequences in COVID-19 recovery patients. However, there are no actual internationally validated guidelines about this topic, due to the relatively newly introduced clinical condition; in addition, a standardized psychopharmacologic treatment of these cases is a complex goal to achieve due to the risk of both drug-drug interactions and the vulnerable conditions of those patients. The aim of this systematic review and case series is to evaluate and gather the scientific evidence on pharmacologic handling during delirium in COVID-19 patients to provide practical recommendations on the optimal management of psychotropic medication in these kinds of patients. The electronic databases PubMed, Embase and Web of Science were reviewed to identify studies, in accordance with the PRISMA guidelines. At the end of the selection process, a total of 21 studies (n = 2063) were included. We also collected a case series of acute psychomotor agitation in COVID-19 patients hospitalized in ICU. Our results showed how the symptom-based choice of the psychotropic medication is crucial, and even most of the psychotropic drug classes showed good safety, one must not underestimate the possible drug interactions and also the possible decrease in vital functions which need to be strictly monitored especially during treatment with some kinds of molecules. We believe that the evidence-based recommendations highlighted in the present research will enhance the current knowledge and could provide better management of these patients.

Keywords: COVID-19 (coronavirus disease 2019); SARS-CoV-2; acute psychosis; delirium; psychomotor agitation; restlessness.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. No specific grant from any funding agency in the public, commercial, or not-for-profit sectors exist.

Figures

Figure 1
Figure 1
PRISMA flow diagram of the study selection process. PRISMA, Preferred Reporting Items for Systematic reviews and Meta-Analyses.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Rogers J.P., Chesney E., Oliver D., Pollak T.A., McGuire P., Fusar-Poli P., Zandi M.S., Lewis G., David A.S. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: A systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7:611–627. doi: 10.1016/S2215-0366(20)30203-0. - DOI - PMC - PubMed
    1. Desforges M., Le Coupanec A., Dubeau P., Bourgouin A., Lajoie L., Dube M., Talbot P.J. Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System? Viruses. 2019;12:14. doi: 10.3390/v12010014. - DOI - PMC - PubMed
    1. Parker C., Slan A., Shalev D., Critchfield A. Abrupt Late-onset Psychosis as a Presentation of Coronavirus 2019 Disease (COVID-19): A Longitudinal Case Report. J. Psychiatr. Pract. 2021;27:131–136. doi: 10.1097/PRA.0000000000000533. - DOI - PMC - PubMed
    1. Clouden T.A. Persistent Hallucinations in a 46-Year-Old Woman After COVID-19 Infection: A Case Report. Cureus. 2020;12:e11993. doi: 10.7759/cureus.11993. - DOI - PMC - PubMed
    1. Wu Y., Xu X., Chen Z., Duan J., Hashimoto K., Yang L., Liu C., Yang C. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav. Immun. 2020;87:18–22. doi: 10.1016/j.bbi.2020.03.031. - DOI - PMC - PubMed

Publication types

Substances